Diamyd Medical AB - Earning & Dividend Analysis Snapshot

This detailed Report provides an Earnings and Dividends history for Diamyd Medical AB. Tabular results include up to a ten-year history of "as reported" Earnings per Share and Dividends per Share plus a calculation of the amount of earnings paid out over the year in dividends (i.e. Payout Ratio). Earnings and Dividends are presented on both a Quarterly and Annual basis. An annual Percent Change factor is calculated for both Earnings and Dividends.

Diamyd Medical AB. The Group's primary activity is the development of medicine for diabetes. The Group operates in two segments: GAD technology and NTDDS technology. The GAD technology segment comprises of GAD-protein and Diamyd anti-GAD RIA-kits. The products are sold to researchers and laboratories. The NTDDS segment include the Group's first drug candidate from theNerve Targeting Drug Delivery System (NTDDS) gene therapy platform. The Group operates globally.

Not the Report you are looking for? Click here for more browsing options.

view sample Single Report

view sample All Basic Reports

Layout and Content of a Typical Report